These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 25168617)

  • 1. Focal therapy for treatment of the small renal mass: dealer's choice or a therapeutic gamble?
    Kutikov A; Smaldone MC; Uzzo RG
    Eur Urol; 2015 Feb; 67(2):260-1. PubMed ID: 25168617
    [No Abstract]   [Full Text] [Related]  

  • 2. Re: Comparison of Partial Nephrectomy and Percutaneous Ablation for cT1 Renal Masses.
    Laguna MP
    J Urol; 2015 Aug; 194(2):331. PubMed ID: 26195356
    [No Abstract]   [Full Text] [Related]  

  • 3. Re: R. Houston Thompson, Tom Atwell, Grant Schmit, et al. Comparison of Partial Nephrectomy and Percutaneous Ablation for cT1 Renal Masses. Eur Urol 2015;67:252-9.
    Zargar H; Coelho RF; Kaouk JH
    Eur Urol; 2015 Feb; 67(2):e23. PubMed ID: 25266972
    [No Abstract]   [Full Text] [Related]  

  • 4. Re: R. Houston Thompson, Tom Atwell, Grant Schmit, et al. Comparison of partial nephrectomy and percutaneous ablation for cT1 renal masses. Eur Urol 2015;67:252-9.
    Mouracade P
    Eur Urol; 2015 Oct; 68(4):e82-3. PubMed ID: 26033152
    [No Abstract]   [Full Text] [Related]  

  • 5. Re: R. Houston Thompson, Tom Atwell, Grant Schmit, et al. Comparison of partial nephrectomy and percutaneous ablation for cT1 renal masses. Eur Urol 2015;67:252-9.
    Potretzke AM; Larson JA; Bhayani SB
    Eur Urol; 2015 Feb; 67(2):e19-20. PubMed ID: 25269382
    [No Abstract]   [Full Text] [Related]  

  • 6. Reply to Pascal Mouracade's letter to the editor re: R. Houston Thompson, Tom Atwell, Grant Schmit, et al. Comparison of partial nephrectomy and percutaneous ablation for cT1 renal masses. Eur Urol 2015;67:252-9.
    Thompson RH; Atwell T; Schmit G; Lohse CM; Kurup AN; Weisbrod A; Psutka SP; Stewart SB; Callstrom MR; Cheville JC; Boorjian SA; Leibovich BC
    Eur Urol; 2015 Oct; 68(4):e84-5. PubMed ID: 26058957
    [No Abstract]   [Full Text] [Related]  

  • 7. Reply to Aaron M. Potretzke, Jeffrey A. Larson and Sam B. Bhayani's Letter to the Editor re: R. Houston Thompson, Tom Atwell, Grant Schmit, et al. Comparison of Partial Nephrectomy and Percutaneous Ablation for cT1 Renal Masses. Eur Urol 2015;67:252-9.
    Thompson RH; Atwell T; Schmit G; Lohse CM; Kurup AN; Weisbrod A; Psutka SP; Stewart SB; Callstrom MR; Cheville JC; Boorjian SA; Leibovich BC
    Eur Urol; 2015 Feb; 67(2):e21-2. PubMed ID: 25257031
    [No Abstract]   [Full Text] [Related]  

  • 8. Reply to Homayoun Zargar, Rafael F. Coelho and Jihad H. Kaouk's Letter to the Editor re: R. Houston Thompson, Tom Atwell, Grant Schmit, et al. Comparison of Partial Nephrectomy and Percutaneous Ablation for cT1 Renal Masses. Eur Urol 2015;67:252-9.
    Thompson RH; Atwell T; Schmit G; Lohse CM; Kurup AN; Weisbrod A; Psutka SP; Stewart SB; Callstrom MR; Cheville JC; Boorjian SA; Leibovich BC
    Eur Urol; 2015 Feb; 67(2):e24-5. PubMed ID: 25257032
    [No Abstract]   [Full Text] [Related]  

  • 9. Laparoscopic radical nephrectomy and minimally invasive surgery for kidney cancer.
    Janzen NK; Perry KT; Schulam PG
    Cancer Treat Res; 2003; 116():99-117. PubMed ID: 14650828
    [No Abstract]   [Full Text] [Related]  

  • 10. Editorial comment.
    Huang WC
    Urology; 2011 Jul; 78(1):98. PubMed ID: 21712114
    [No Abstract]   [Full Text] [Related]  

  • 11. Novel concepts in the treatment of localized renal cell carcinoma.
    Al-Geizawi SM; Awaidat RA; Sawah SI; Khauli RB
    J Med Liban; 2005; 53(2):80-4. PubMed ID: 16604992
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimal management of localized renal cell carcinoma: surgery, ablation, or active surveillance.
    Chen DY; Uzzo RG
    J Natl Compr Canc Netw; 2009 Jun; 7(6):635-42; quiz 643. PubMed ID: 19555585
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Renal surgery--is technique more important than tumor or patient characteristics in preserving kidney function?
    Goldfarb DA
    J Urol; 2011 Feb; 185(2):383-4. PubMed ID: 21168169
    [No Abstract]   [Full Text] [Related]  

  • 14. [Pro percutaneous-ablative tumor therapy].
    Brehmer B; Jakse G
    Aktuelle Urol; 2007 Mar; 38(2):101-3. PubMed ID: 17438641
    [No Abstract]   [Full Text] [Related]  

  • 15. Is radiofrequency ablation for small kidney tumors ready for prime time?
    Goh AC; Gill IS
    Eur Urol; 2012 Jun; 61(6):1162-3; discussion 1163-4. PubMed ID: 22402112
    [No Abstract]   [Full Text] [Related]  

  • 16. Salvage ablation for partial nephrectomy failures.
    Raman JD
    Can J Urol; 2013 Oct; 20(5):6938. PubMed ID: 24128833
    [No Abstract]   [Full Text] [Related]  

  • 17. [Nephron-sparing therapy for renal tumors].
    Brehmer B; Mahnke AH; Jakse G
    Aktuelle Urol; 2007 Mar; 38(2):126-31; discussion 125. PubMed ID: 17390274
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CIRSE Guidelines on Percutaneous Ablation of Small Renal Cell Carcinoma.
    Krokidis ME; Orsi F; Katsanos K; Helmberger T; Adam A
    Cardiovasc Intervent Radiol; 2017 Feb; 40(2):177-191. PubMed ID: 27987000
    [No Abstract]   [Full Text] [Related]  

  • 19. Emerging surgical treatments for renal cell carcinoma.
    Husain FZ; Badani KK; Sfakianos JP; Mehrazin R
    Future Oncol; 2016 Apr; 12(7):921-9. PubMed ID: 26892144
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The future of nephron sparing procedures for renal masses: balancing costs, efficacy, patient outcomes and experience.
    Lotan Y
    J Urol; 2011 May; 185(5):1560-1. PubMed ID: 21419436
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.